Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)
Clinical trial NCT01703221 · COMPLETED
Trial details
- NCT number
- NCT01703221
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-24
- Primary completion
- 2014-04-25
- Enrollment
- 414
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.